Philadelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia.
De Melo
Valeria A S
VA
Milojkovic
Dragana
D
Khorashad
Jamshid S
JS
Marin
David
D
Goldman
John M
JM
Apperley
Jane F
JF
Reid
Alistair G
AG
D002869:Chromosome Aberrations / Q000187:drug effects*; D002999:Clone Cells; D000069439:Dasatinib; D006410:Hematopoiesis / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics*; D010677:Philadelphia Chromosome; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib